Article Image
IPFS News Link • Vaccines and Vaccinations

Pfizer In Regular Contact With Biden Campaign, Expects To Seek Vaccine Emergency Approval Friday

•, by Tyler Durden

Meanwhile, the AP reported that Pfizer is already in "regular communication" with President-elect Joe Biden's transition team as part of the ongoing efforts to keep all parties up-to-date on the vaccine and its distribution. It's part of a patchwork of "workarounds" that Biden is using as President Trump refuses to cooperate with his former Democratic rival, according to the AP.

After confirming yesterday that its Phase 3 vaccine trial had finally recorded its last confirmed COVID-19 infection needed before applying for an emergency use approval from the FDA, Pfizer Wednesday morning has just released a summary of its "final" data which - as luck would have it - showed the Pfizer vaccine is actually 95% effective, leaving it on par with Moderna's vaccine.

On the surface, this final number seems to be an improvement on the 90%+ effective preliminary finding released by Pfizer last week. What's more, the new data answered a critical question posed by experts: how effective is the vaccine on older and more vulnerable patients? Pfizer and Biontech said Wednesday that the  vaccine's efficacy in people older than 65 was more than 94%.

According to WSJ, now that the final data is in, Pfizer expects to apply for the EUA within days, the company said Wednesday.

Shares were trading almost 4% higher in premarket on the news.

Free Talk Live